ES2120962T3 - Composicion antivirica. - Google Patents
Composicion antivirica.Info
- Publication number
- ES2120962T3 ES2120962T3 ES91910575T ES91910575T ES2120962T3 ES 2120962 T3 ES2120962 T3 ES 2120962T3 ES 91910575 T ES91910575 T ES 91910575T ES 91910575 T ES91910575 T ES 91910575T ES 2120962 T3 ES2120962 T3 ES 2120962T3
- Authority
- ES
- Spain
- Prior art keywords
- composition
- antiviral
- present
- antivirica
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
UNA COMPOSICION ANTIVIRICA QUE COMPRENDE PROSTRATINA, UN DERIVADO DEL ESTER DE FORBOL, Y UN PORTADOR FARMACEUTICAMENTE ACEPTABLE, A LA VEZ QUE TIENE ACTIVIDAD ANTIVIRICA, NO TIENE ACTIVIDAD SUBSTANCIAL TUMORAL NI TIENE OTRAS PROPIEDADES TOXICOLOGICAS ADVERSAS SUBSTANCIALES QUE IMPEDIRIAN SU EMPLEO EN LA TERAPIA ANTIVIRICA. SE INCLUYEN LOS METODOS DE TRATAMIENTO DE LOS PACIENTES CON INFECCIONES VIRICAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53056290A | 1990-05-30 | 1990-05-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2120962T3 true ES2120962T3 (es) | 1998-11-16 |
Family
ID=24114097
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES91910575T Expired - Lifetime ES2120962T3 (es) | 1990-05-30 | 1991-05-24 | Composicion antivirica. |
Country Status (10)
Country | Link |
---|---|
US (1) | US5599839A (es) |
EP (1) | EP0531413B1 (es) |
JP (1) | JPH0737380B2 (es) |
AT (1) | ATE170075T1 (es) |
AU (1) | AU639343B2 (es) |
CA (1) | CA2083945C (es) |
DE (1) | DE69130063T2 (es) |
DK (1) | DK0531413T3 (es) |
ES (1) | ES2120962T3 (es) |
WO (1) | WO1991018595A1 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1924548B1 (en) | 2005-07-13 | 2018-03-28 | Salvia Sciences, Inc. | Ester prodrugs of prostratin and related phorbol compounds |
US11696908B2 (en) | 2007-01-31 | 2023-07-11 | Biosuccess Biotech Co. Ltd. | Compositions and methods of use of phorbol esters |
US9636317B2 (en) | 2007-01-31 | 2017-05-02 | Biosuccess Biotech Co. Ltd. | Compositions and methods of use of phorbol esters |
US11564901B2 (en) | 2007-01-31 | 2023-01-31 | Biosuccess Biotech Co., Ltd. | Compositions and methods of use of phorbol esters |
US10369222B2 (en) | 2012-01-18 | 2019-08-06 | Biosuccess Biotech Co., Ltd. | Compositions and methods of use of phorbol esters for the treatment of stroke |
PL2368555T3 (pl) * | 2007-01-31 | 2017-02-28 | Biosuccess Biotech Company | Kompozycje i sposoby stosowania estrów forbolu |
US9974764B2 (en) | 2007-01-31 | 2018-05-22 | Biosuccess Biotech Co. Ltd. | Compositions and methods of use of phorbol esters in the treatment of neoplasms |
US9533938B2 (en) | 2007-01-31 | 2017-01-03 | Biosuccess Biotech Co., Ltd. | Compositions and methods of use of phorbol esters for the treatment of stroke |
US8067632B2 (en) | 2007-07-26 | 2011-11-29 | The Board Of Trustees Of The Leland Stanford Junior University | Process to produce prostratin and structural or functional analogs thereof |
EP2276478A4 (en) * | 2008-04-11 | 2012-03-07 | Aids Res Alliance | METHOD FOR THE ADMINISTRATION OF PROSTRATIN AND STRUCTURAL ANALOGUE THEREOF |
US20100298171A1 (en) * | 2009-05-22 | 2010-11-25 | Affymetrix, Inc. | Apparatus for polymer synthesis |
CN102724990A (zh) * | 2009-07-29 | 2012-10-10 | 印第安纳大学研究及科技有限公司 | 药用植物的提取物及其应用 |
US9550722B2 (en) | 2012-01-18 | 2017-01-24 | Biosuccess Biotech Co. Ltd. | Compositions and methods of use of phorbal esters for the treatment of stroke |
US10099996B2 (en) | 2012-01-18 | 2018-10-16 | Biosuccess Biotech Co. Ltd. | Compositions and methods of use of phorbol esters in the treatment of neoplasms |
ITUB20153575A1 (it) * | 2015-09-11 | 2017-03-11 | Fca Italy Spa | "Sospensione per una ruota sterzante di autoveicolo, con asse di sterzo semi-virtuale" |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4902716A (en) * | 1984-12-18 | 1990-02-20 | Harbor Branch Oceanographic Institutuion, Inc. | Anti-viral chamigrene derivatives |
-
1991
- 1991-05-24 ES ES91910575T patent/ES2120962T3/es not_active Expired - Lifetime
- 1991-05-24 EP EP91910575A patent/EP0531413B1/en not_active Expired - Lifetime
- 1991-05-24 CA CA002083945A patent/CA2083945C/en not_active Expired - Lifetime
- 1991-05-24 AU AU79099/91A patent/AU639343B2/en not_active Expired
- 1991-05-24 DK DK91910575T patent/DK0531413T3/da active
- 1991-05-24 WO PCT/US1991/003619 patent/WO1991018595A1/en active IP Right Grant
- 1991-05-24 JP JP3510273A patent/JPH0737380B2/ja not_active Expired - Lifetime
- 1991-05-24 DE DE69130063T patent/DE69130063T2/de not_active Expired - Lifetime
- 1991-05-24 AT AT91910575T patent/ATE170075T1/de not_active IP Right Cessation
-
1995
- 1995-04-17 US US08/424,558 patent/US5599839A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0531413A1 (en) | 1993-03-17 |
JPH05506451A (ja) | 1993-09-22 |
DK0531413T3 (da) | 1999-05-25 |
WO1991018595A1 (en) | 1991-12-12 |
DE69130063D1 (de) | 1998-10-01 |
US5599839A (en) | 1997-02-04 |
AU639343B2 (en) | 1993-07-22 |
JPH0737380B2 (ja) | 1995-04-26 |
AU7909991A (en) | 1991-12-31 |
DE69130063T2 (de) | 1999-02-25 |
ATE170075T1 (de) | 1998-09-15 |
EP0531413B1 (en) | 1998-08-26 |
EP0531413A4 (en) | 1993-06-16 |
CA2083945C (en) | 1995-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MD1224B2 (en) | Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B | |
ES2120962T3 (es) | Composicion antivirica. | |
PT911033E (pt) | Utilizacao do interferao de consenso para a reducao dos efeitos secundarios do tratamento com interferoes na hepatite viral | |
BG91270A (bg) | Антивирусно и антибактериално средство и метод за използването му | |
ATE87214T1 (de) | Verwendung katabolischer enzyme zur herstellung eines medikaments zum bekaempfen der erworbenen immunschwaeche (aids) und deren vorstadien (las, arc). | |
FI922325A (fi) | Oral sammansaettning foer botning av inflammatoriska tarmkanalsjukdomar. | |
ATE197670T1 (de) | Parenterales busulfan zur behandlung von malignen krankheiten | |
AP9100310A0 (en) | Tnf inhibitors | |
IE40860B1 (en) | Substituted benzamides | |
ATE26216T1 (de) | Zusammensetzungen mit gehalt an interferon und ihre therapeutische anwendung. | |
AU563831B2 (en) | N-(2-amino-3,5-dibromobenzyl)- trans-4-amino-cyclohexanol derivatives | |
HU907654D0 (en) | Process for the production of medical preparations with increased stabilization, and without tissue-harming effect | |
ES2058343T3 (es) | Piridinas disubstituidas. | |
FR2361404A1 (fr) | Nouvelles 7-boxyiminoacylcephalosporines, leurs procedes de preparation et leur application en therapeutique | |
ATE76579T1 (de) | Interferon-zusammensetzungen. | |
DE69019404D1 (de) | Derivate von Penciclovir zur Behandlung von Hepatitis-B-Infektionen. | |
FI922428A0 (fi) | Nya 2-amino-5-cyan-1,4- dihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel. | |
IL97054A0 (en) | Pharmaceutical compositions comprising buspirones for the treatment of sleep apneas | |
ES8704962A1 (es) | Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida. | |
ES8607728A1 (es) | Procedimiento de preparacion de una nueva composicion anti- biotica sinergetica, de uso veterinario | |
ATE36957T1 (de) | N,n-diethyl-5-methyl-2h,1-benzothiopyrano-(4,3, - cd)-indazol-2-ethanamine, diese enthaltende zubereitungen und ihre verwendung. | |
IT217790Z2 (it) | Telaio per cassetti di mobili. | |
EP0459176A3 (en) | Oligophosphates with antiviral activity | |
DE69210737D1 (de) | Verwendung von L-2-Oxothiazolidine-4-Carboxylate zur Herstellung eines Arzneimittels zur Behandlung von latenten HIV-Infektionen | |
ATE210445T1 (de) | Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 531413 Country of ref document: ES |